Ciphergen to Webcast Presentation at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference, Monaco
May 08 2007 - 5:30PM
PR Newswire (US)
FREMONT, Calif., May 8 /PRNewswire-FirstCall/ -- Ciphergen
(NASDAQ:CIPH) announced today that it will webcast its presentation
at the Rodman & Renshaw's Global Healthcare Conference in
Monaco. Gail Page, President & CEO, will provide a company
overview at 5:10 a.m. EDT on Monday, May 14, 2006. A webcast of the
presentation will be available live and by replay. To access both
the live and archived webcast, please go to
http://www.ciphergen.com/ and click on the "Investors" link. The
archived replay will be available for 24 hours after the live
presentation and will be accessible for 30 days. About Ciphergen
Ciphergen Biosystems, Inc. is dedicated to the discovery,
development and commercialization of novel high-value diagnostic
tests that help physicians diagnose, treat and improve outcomes for
patients. Ciphergen, along with its prestigious scientific
collaborators, has ongoing diagnostic programs in oncology,
cardiology and women's health with an initial focus in ovarian
cancer. Based in Fremont, California, more information about
Ciphergen can be found on the Web at http://www.ciphergen.com/.
DATASOURCE: Ciphergen Biosystems, Inc. CONTACT: Sue Carruthers,
Investor Relations of Ciphergen Biosystems, Inc., +1-510-505-2297
Web site: http://www.ciphergen.com/
Copyright
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From Jul 2023 to Jul 2024